Microbiology

ASSET is close to its conclusion and a concluding conference will be held in Rome, on October 30-31, to present all the main outcomes of the project. This event will take place at the hotel NH Roma Leonardo Da Vinci and will be targeted to a selected audience of EU stakeholders and policy makers. Its aim is to enhance advocacy and intersectoral approach in a multisetting scenario applied to fostering preparedness and response toward Public Health Emergency of International Concern (PHEIC), like epidemics and even pandemics.

In 1347, Siena, a flourishing, beautiful city-state on Tuscany hills, was a leading world power for its age. Just one year later, plague had already killed almost half of its inhabitants, changing its history forever. That did not happen only there: the impact of the Black Death – as the Middle Age epidemic was named – involved all Europe, with huge human, economic, political and cultural consequences. A typical, extreme, example of how infectious diseases can influence the course of history.

Vaccines have had broad medical impact, but existing vaccine technologies and production methods are limited in their ability to respond to certain pathogens. Other hurdles are due to difficulties in large scale production. MycoSynVac project proposes a new way for developing vaccines, by using of cutting-edge synthetic biology methodologies to engineer Mycoplasma pneumoniae as a universal chassis for vaccination.